International Workshop on Prenatal Screening
2021
Clinical implementation of first trimester pre-eclampsia screening
Available now on-demand! Duration: 1,5 h
The presentation focus will be on clinical implementation of first trimester pre-eclampsia screening in different set-ups and countries. You will have the possibility to interact live with 5 of the most outstanding professionals in prenatal screening and address your questions directly to the experts.
A Certificate of Attendance will be sent to participants.
Agenda
- Welcome from Chairman
Prof. Kevin Spencer
Former Consultant Biochemist & Clinical Lead, Kings George Hospital, London, UK - Ultrasound aspects and implementation in Hong Kong
Dr. Liona Poon
Professor (Clinical), Prince of Wales Hospital, Hong Kong - Lab perspective and implementation in Toulouse
Dr. Safouane Hamdi
Assistant-Professor of Hormonology and Senior Researcher at the Research Group on Human Fertility Toulouse University, France - Health economic aspects and implementation in Dresden
Prof. Cahit Birdir
Head of Obstetrics and Prenatal Medicine, Universitätsfrauenklinik Dresden, Germany - Implementation and effectiveness of early PE screening in London
Prof. Basky Thilaganathan
Professor in Fetal Medicine and Consultant Obstetrician and Director, Fetal Medicine Unit St Georges, St George’s Hospital, London, UK - Closing
Let’s stay connected!
Continue receiving Thermo Fisher Scientific emails and content by clicking the Subscribe button below.
Learn more about pre-eclampsia >
2020
Pre-eclampsia management throughout pregnancy
in times of COVID-19
The webinar held on June 17th, 2020 at 4:00pm CET
This webinar provided the latest scientific information on pre-eclampsia screening and its management throughout pregnancy – especially in the current period of COVID-19.
Speakers
Dr. C. Birdir, University Hospital Dresden, Germany
Implementing first trimester pre-eclampsia screening in a model region in Germany
Prof. S. Verlohren, Charité Berlin, Germany
How to deal with high risk pre-eclampsia pregnancies in the times of COVID-19
Due to confidential agreements we cannot provide the presentation of Prof. Verlohren and we do hope for your understanding.
2019
11th International Workshop on Prenatal Screening - Berlin 2019
We are very pleased to share the following lectures as pdf files.
|
State of the art of first trimester preeclampsia screening - Pr. da Costa |
|
|
KRYPTOR GOLD / Inhibin A: FMF certification |
|
|
Patients view / World PE day |
|
|
Contingent screening / NIPT guidelines |
|
|
Great obstetrical syndromes: screening and prevention - Pr. Bujold |
|
|
FMF concept of pre-eclampsia and IUGR screening throughout pregnancy - Dr. Döbert |
|
|
1st trimester pre-eclampsia screening: implementation into routine - Dr. de Paco |
Download presentation > |
|
Screening and prevention for late-onset PE: STATIN trial - Dr. Panaitescu |
Download presentation > |
2018
10th International Workshop on Prenatal Screening - Berlin 2018
We are very pleased to share the following lectures as pdf files.
|
Preeclampsia screening: time for implementation - Dr. Mar Gil |
|
|
The Danish PNS program: including pre-eclampsia and NIPT - Dr. Petersen |
|
|
Counselling patients in times of NIPT - Prof. Kozlowski |
|
|
1st trimester pre-eclampsia screening: PREVAL study - Dr. Santacruz |
|
|
3rd trimester pre-eclampsia screening: STATIN study - Dr. Döbert |
|
|
Health economic aspects of preeclampsia management - Prof. Stepan |
|
|
Guidelines on preeclampsia management - Dr. Verlohren |
Download presentation > |
|
Quiz (FMF algorithm on adverse outcomes other than T21) - Prof. Kagan |
Download presentation > |
2017
9th International Workshop on Prenatal Screening - Berlin 2017
We are very pleased to share most of the lectures as pdf files and videos.
|
Ensuring high quality NIPT There is a lack of external quality control scheme for cfDNA prenatal tests. Dr. Deans, the scheme director of UK NEQAS, introduces the EQA pilot project. |
|
|
|
|
|
Contingent Model in Switzerland Prof. Dr. Tercanli shares experience of cfDNA and contingent screening implementation in Switzerland, discusses results and learnings for the last year. |
|
|
|
|
|
Cell-free DNA FMF contingent screening Dr.Gil presents FMF studies about performance of cfDNA/NIPT test, screened conditions, interpretation of results and a model of clinical implementation. |
|
|
|
|
|
Prediction of stillbirth Prof. Akolekar describes methods and performance of stillbirth screening. |
|
|
|
|
|
Screening for pre-eclampsia in 2nd and 3rd trimesters Prof. Birdir describes a way to screen for late-onset form of preeclampsia in routine population around week 34. |
|
|
|
|
|
Pyramid of care – Importance of ultrasound Prof. Kagan describes a first trimester screening approach in weeks 11-13 to detect pregnancy complications as trisomies, preeclampsia, IUGR, preterm birth. |
|
|
|
|
|
Implementing pre-eclampsia screening - Czech experience Prof. Lubusky describes the way preeclampsia screening is performed at his university clinic in Czech Republic. |